This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Glossary
- ABC=
- ATP binding cassette;
- ABCA1=
- ABC transporter protein family member A1;
- AD=
- Alzheimer disease;
- apoE=
- apolipoprotein E;
- APP=
- amyloid precursor protein;
- ATP=
- adenosine triphosphate;
- CoA=
- coenzyme A;
- CYP=
- cytochrome P;
- 7-DHC=
- 7-dehydrocholesterol;
- ER=
- endoplasmic reticulum;
- HD=
- Huntington disease;
- HDL=
- high-density lipoprotein;
- HMG-CoA=
- 3-hydroxy-3-methyglutaryl-CoA;
- HMGR=
- HMG-CoA reductase;
- LDLR=
- low-density lipoprotein receptors;
- LTP=
- long-term potentiation;
- LXR=
- liver X-activated receptor;
- NMDA=
- N-methyl-d-aspartate;
- NPC=
- Niemann-Pick type C;
- 24-OHC=
- 24-hydroxy cholesterol;
- SHH=
- sonic hedgehog;
- SRE-1=
- sterol-regulated element-1;
- SREBP=
- sterol-regulated element binding protein.
The human brain accounts for 2% of the whole body mass, yet it contains approximately 25% of the total cholesterol of the body. Cholesterol is a major lipid constituent of the myelin sheath and the membrane lipid rafts in neurons and astrocytes. It has an important role in brain development and neuronal function by regulating cell signaling pathways, gene transcription, and availability of bioactive steroids.1–4 Cholesterol synthesis and metabolism in the brain involve complex interactions between astrocytes and neurons.1–4 Abnormalities in cholesterol metabolism in the CNS occur in several neurologic disorders, including Niemann-Pick type C5 and Smith-Lemli-Opitz syndrome.6 Prominent neurologic manifestations also occur in disorders of peripheral cholesterol metabolism, such as cerebrotendinous xanthomatosis7 and Tangier disease.8 Brain cholesterol has also been implicated in the pathogenesis of Alzheimer disease (AD)2,3,9–11 and Huntington disease.12 The metabolism of cholesterol in the brain and its implications for neurologic disease have been extensively reviewed.1–4,10–12
SYNTHESIS AND METABOLISM OF CHOLESTEROL IN THE BRAIN
Cholesterol is a crucial component of mammalian membranes. Most brain cholesterol is unesterified and primarily localized in myelin sheaths. Cholesterol is also concentrated in plasma membrane domains called lipid rafts13,14 in neurons and astrocytes. The cholesterol content of the CNS is largely independent of dietary uptake or hepatic synthesis, as circulating cholesterol does not cross the blood–brain barrier. Brain cholesterol turnover is extremely slow, with a half-life estimated in years in humans.1,4
Synthesis and recycling.
Neurons need to maintain the large membrane surface of their dendritic processes and axonal projections. In addition, cholesterol concentration at the lipid rafts critically regulates ion channel permeability, signal transduction, synaptogenesis, and synaptic vesicle dynamics.13,14 Thus a tight control of cholesterol homeostasis is critical for neuronal function. Although neurons can synthesize cholesterol, astrocytes are the main source of cholesterol for neurons1,4 (figure). The first steps of …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg